pFortune India’s latest issue dives into span classwhitespace-normalBioconspan’s future-focused strategy, as founder span classwhitespace-normalKiran Mazumdar-Shawspan outlines a well-defined succession plan to ensure seamless leadership continuity and sustained growth. In a detailed interaction, she shares her vision for future-proofing the company she built. Meanwhile, in another significant development, span classwhitespace-normalDilip Shanghvispan makes a bold global move with span classwhitespace-normalSun Pharmaspan’s 11.75 billion acquisition of span classwhitespace-normalOrganonspan, strengthening its position in women’s health and biosimilars. The issue also captures the surge of over 70 billion in investments transforming India’s rapidly expanding data centre ecosystem, with major conglomerates and global tech giants competing for scale and dominance.p